Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 5758195, 12 pages
http://dx.doi.org/10.1155/2016/5758195
Research Article

Synergistic Effects of Danshen (Salvia Miltiorrhiza Radix et Rhizoma) and Sanqi (Notoginseng Radix et Rhizoma) Combination in Inhibiting Inflammation Mediators in RAW264.7 Cells

1National Institute of Complementary Medicine (NICM), Western Sydney University, Locked Bag 1797, Penrith, NSW 2751, Australia
2South Western Sydney Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia
3Molecular Biology, Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798
4School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, UK
5Faculty of Sciences, TCM Division, University of Technology Sydney, Main Campus, P.O. Box 123, Broadway, NSW 2007, Australia

Received 17 July 2016; Accepted 21 September 2016

Academic Editor: Hanrui Zhang

Copyright © 2016 Xian Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. D. Intengan and E. L. Schiffrin, “Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis,” Hypertension, vol. 38, no. 3, pp. 581–587, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. S. H. Saydah, J. Fradkin, and C. C. Cowie, “Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes,” The Journal of the American Medical Association, vol. 291, no. 3, pp. 335–342, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. D. H. Endemann and E. L. Schiffrin, “Endothelial dysfunction,” Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 1983–1992, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Heitzer, T. Schlinzig, K. Krohn, T. Meinertz, and T. Münzel, “Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease,” Circulation, vol. 104, no. 22, pp. 2673–2678, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Libby, P. M. Ridker, and A. Maseri, “Inflammation and atherosclerosis,” Circulation, vol. 105, no. 9, pp. 1135–1143, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. A. H. Sprague and R. A. Khalil, “Inflammatory cytokines in vascular dysfunction and vascular disease,” Biochemical Pharmacology, vol. 78, no. 6, pp. 539–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Zhang, Y. Park, J. Wu et al., “Role of TNF-α in vascular dysfunction,” Clinical Science, vol. 116, no. 3, pp. 219–230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. D. Chauhan, G. Seggara, P. A. Vo, R. J. Macallister, A. J. Hobbs, and A. Ahluwalia, “Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice,” The FASEB Journal, vol. 17, no. 6, pp. 773–775, 2003. View at Google Scholar · View at Scopus
  9. X. Gao, S. Belmadani, A. Picchi et al., “Tumor necrosis factor-α induces endothelial dysfunction in Lepr db mice,” Circulation, vol. 115, no. 2, pp. 245–254, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Paz, I. Frolkis, and D. Pevni, “Effect of tumor necrosis factor-alpha on endothelial and inducible nitric oxide synthase mRNA expression and nitric oxide synthesis in ischemic and nonischemic isolated rat heart,” Journal of the American College of Cardiology, vol. 42, pp. 1299–1305, 2003. View at Google Scholar
  11. J. L. Zhang, J. M. Patel, Y. D. Li, and E. R. Block, “Proinflammatory cytokines downregulate gene expression and activity of constitutive nitric oxide synthase in porcine pulmonary artery endothelial cells,” Research Communications in Molecular Pathology and Pharmacology, vol. 96, no. 1, pp. 71–87, 1997. View at Google Scholar · View at Scopus
  12. I. F. Charo and M. B. Taubman, “Chemokines in the pathogenesis of vascular disease,” Circulation Research, vol. 95, no. 9, pp. 858–866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Tang, H.-L. Xue, C.-L. Bai, and R. Fu, “Regulation of adhesion molecules expression in TNF-α-stimulated brain microvascular endothelial cells by tanshinone IIA: involvement of NF-κB and ROS generation,” Phytotherapy Research, vol. 25, no. 3, pp. 376–380, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Zhou, S. W. Seto, D. Chang et al., “Synergistic effects of Chinese herbal medicine: a comprehensive review of methodology and current research,” Frontiers in Pharmacology, vol. 7, article 201, 2016. View at Publisher · View at Google Scholar
  15. National Pharmacopoeia Committee, Pharmacopoeia of the People's Republic of China, vol. 1, China Medica Science Press, Beijing, China, 2010.
  16. K.-T. Ji, J.-D. Chai, C. Xing, J.-L. Nan, P.-L. Yang, and J.-F. Tang, “Danshen protects endothelial progenitor cells from oxidized low-density lipoprotein induced impairment,” Journal of Zhejiang University: Science B, vol. 11, no. 8, pp. 618–626, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. G.-W. Fan, X.-M. Gao, H. Wang et al., “The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 113, no. 3–5, pp. 275–280, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. J. Jeon, K. H. Son, Y. S. Kim, Y. H. Choi, and H. P. Kim, “Inhibition of prostaglandin and nitric oxide production in lipopolysaccharide-treated RAW 264.7 cells by tanshinones from the roots of Salvia miltiorrhiza bunge,” Archives of Pharmacal Research, vol. 31, no. 6, pp. 758–763, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Li, L. Zhang, R.-L. Cai, Y. Gao, and Y. Qi, “Lipid-soluble extracts from Salvia miltiorrhiza inhibit production of LPS-induced inflammatory mediators via NF-κB modulation in RAW 264.7 cells and perform antiinflammatory effects in vivo,” Phytotherapy Research, vol. 26, no. 8, pp. 1195–1204, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. J.-S. Fan, D.-N. Liu, G. Huang et al., “Panax notoginseng saponins attenuate atherosclerosis via reciprocal regulation of lipid metabolism and inflammation by inducing liver X receptor alpha expression,” Journal of Ethnopharmacology, vol. 142, no. 3, pp. 732–738, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Liu, H.-G. Zhang, Y. Jia, and X.-H. Li, “Panax notoginseng saponins attenuate atherogenesis accelerated by zymosan in rabbits,” Biological and Pharmaceutical Bulletin, vol. 33, no. 8, pp. 1324–1330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Du, B. Cheng, X. Zhu, and C. Ling, “Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects,” Journal of Immunology, vol. 187, no. 2, pp. 942–950, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. I.-A. Lee, S. R. Hyam, S.-E. Jang, M. J. Han, and D.-H. Kim, “Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages,” Journal of Agricultural and Food Chemistry, vol. 60, no. 38, pp. 9595–9602, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Paul, H. S. Shin, and S. C. Kang, “Inhibition of inflammations and macrophage activation by ginsenoside-Re isolated from Korean ginseng (Panax ginseng C.A. Meyer),” Food and Chemical Toxicology, vol. 50, no. 5, pp. 1354–1361, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. H.-S. So, R. Park, H.-M. Oh et al., “The methanol extract of Spiraea prunifolia var. simpliciflora root inhibits the generation of nitric oxide and superoxide in RAW 264.7 cells,” Journal of Ethnopharmacology, vol. 68, no. 1–3, pp. 209–217, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. T.-C. Chou, “Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies,” Pharmacological Reviews, vol. 58, no. 3, pp. 621–681, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. J. S. Kim, A. S. Narula, and C. Jobin, “Salvia miltiorrhiza water-soluble extract, but not its constituent salvianolic acid B, abrogates LPS-induced NF-κB signalling in intestinal epithelial cells,” Clinical and Experimental Immunology, vol. 141, no. 2, pp. 288–297, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. A. S. Ravipati, L. Zhang, S. R. Koyyalamudi et al., “Antioxidant and anti-inflammatory activities of selected Chinese medicinal plants and their relation with antioxidant content,” BMC Complementary and Alternative Medicine, vol. 12, article 173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. G.-W. Fan, X.-M. Gao, H. Wang et al., “The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS,” Journal of Steroid Biochemistry and Molecular Biology, vol. 113, no. 3–5, pp. 275–280, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. H. Ren, Y. H. Tong, W. Xu, J. Ma, and Y. Chen, “Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression,” Phytomedicine, vol. 17, no. 3-4, pp. 212–218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Xu, P. J. Little, T. Lan et al., “Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in Apolipoprotein-E knockout mice fed a high cholesterol diet,” Archives of Biochemistry and Biophysics, vol. 515, no. 1-2, pp. 72–79, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Rhule, S. Navarro, J. R. Smith, and D. M. Shepherd, “Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264.7 cells,” Journal of Ethnopharmacology, vol. 106, no. 1, pp. 121–128, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Park and Y. C. Jae, “Anti-inflammatory effects of ginsenosides from Panax ginseng and their structural analogs,” African Journal of Biotechnology, vol. 8, no. 16, pp. 3682–3690, 2009. View at Google Scholar · View at Scopus
  34. Q. H. Xu, An Encyclopaedia of Chinese Paired-Herbs, China Press of Traditional Chinese Medicine, Beijing, China, 1996.
  35. R. Wang, H. Shang, Y. Wang, B. Zhang, X. Gao, and Y. Zhao, “Multi-objective optimization research on Danshen-Sanqi using ED-NM-MO technique,” Tianjin Journal of Traditional Chinese Medicine, vol. 23, pp. 242–247, 2006. View at Google Scholar
  36. G. Zeng, Q. Xu, H. Xiao, and X. Liang, “Influence of compatibility ratio of Fufang Danshen on the dissolution of Danshen compositions,” Chinese Journal of Chromatography, vol. 22, no. 2, pp. 141–143, 2004. View at Google Scholar · View at Scopus
  37. X. Li, X. Xu, J. Wang et al., “A system-level investigation into the mechanisms of Chinese Traditional Medicine: compound danshen formula for cardiovascular disease treatment,” PLoS ONE, vol. 7, no. 9, article e43918, 2012. View at Publisher · View at Google Scholar · View at Scopus